29 Sep 2016

I'm Impressed: Belhanda claims 'scary' €20m Liverpool misfit is like 'Zlatan Ibrahimovic'

Mario Balotelli has only a month into his new career at Nice, but he's already picking up admirers, and new team-mate Younes Belhanda is the latest to wax lyrical about the controversial Italian striker.

When asked this week about Balotelli's impact at Nice, Belhanda - a a regular transfer target for Liverpool - raved:

"It's scary to see Mario Balotelli in front of you. Ibrahimovic and Balotelli are talented players, internationally recognized. So when you have a player of that calibre against you, you have a little pressure."

Balotelli has contributed four goals in his first two league games for Nice, but due to a new injury, he missed the club's 1-0 victory over Nancy on Sunday.

Things are going well for Balotelli so far, but according to Nice's president, Jean-Pierre Rivere, Mino Raiola tried to talk put the stoppers on the move. He told L'Equipe:

"Mino gave me all the reasons why I should not sign [Balotelli], and when he arrived, Mino said to him, 'Everything bad I had to say about you to the president, I have said,'".

Clearly, Nice went into this deal with their eyes open (!)

* Jul 2016: Described as an 'incredible talent' by Crotone president Raffaele Vrenna. Cost Liverpool €20m



QUICK LINKS: Latest Transfer News | LFC Highlights | Stats
BEV (LADYLIVERBIRD) UPDATE (From Case)

Bev is having her bone marrow transplant today (Wed19th April). It's a big operation, and she'll be on life support for the duration. The recovery process is going to be very tough and unfortunately carries a great deal of risk with regards to infection, which could be life threatening due to the process requiring her immune system to have been purposefully wiped out beforehand (so that it doesn't f!ght against/reject the transplant). Sadly, the preparation treatment has adversely affected her heart as well and currently it is beating much lower than it should be so we have to hope that soon starts to recover as well. More HERE.

0 Comments:

Post a Comment